© 2022 MJH Life Sciences and NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.
March 29th 2022
Margaret Park, MD, defines typical signs and symptoms of narcolepsy and differentiates between the 2 main types of disease.
Experts in sleep medicine evaluate the impact of narcolepsy on a patient’s quality of life and expand on which symptoms appear to be most debilitating.
April 5th 2022
Russell Rosenberg, PhD, DABSM, and Margaret Park, MD, review the case of a 15-year-old girl who presents with excessive daytime sleepiness and share clinical impressions on diagnosis and treatment.
April 12th 2022
Key opinion leaders in sleep medicine discuss patient recognition of cataplexy symptoms in narcolepsy and their approach to narcolepsy diagnosis.
Drs Margaret Park and Russell Rosenberg discuss challenges in the diagnosis of narcolepsy.
Expert sleep specialists explore the use of nonpharmacologic treatment approaches for the management of narcolepsy.
April 19th 2022
Russell Rosenberg, PhD, DABSM, and Margaret Park, MD, review the optimal treatment selection of pharmacologic options for the management of patients with narcolepsy.
Drs Margaret Park and Russell Rosenberg illuminate challenges patients and providers face with narcolepsy medications, including potential substance abuse with scheduled substances.
April 26th 2022
Expert sleep specialists review the case of a 22-year-old man who is diagnosed with excessive daytime sleepiness and type 2 narcolepsy and his challenges with treatment.
Margaret Park, MD, leads the discussion on setting and managing patient expectations for treatment in narcolepsy.
Cognitive Functioning and Motor Difficulties Identified in Spinal Muscular Atrophy Type 3
Background Factors Drive Elevated Risk of Neonatal Seizures, Epilepsy in Children of Mothers on SSRI/SNRIs
Advocacy’s Part in the Progress in ALS: Matthew B. Harms, MD
This Week on NeurologyLive® — May 16, 2022